Valore prognostico e curativo del linfonodo sentinella nel trattamento chirurgico del cancro della mammella. Analisi di 377 pazienti
Carlo Iannace 1, Lorenzo Di Libero 1, Maria Lepore 2, Noè De Stefano 2, Marcella Buono 3, Valerio Sciascia 1, Fiorenza Manetta 1, Marco Giordano 1, Giovanni Scetta 1, Roberto Varriale 1, Daniela Esposito 1, Ernesto Tartaglia 1, Umberto Ferbo 2, Paolo Miletto 4, Francesco Caracciolo 1
Affiliations
Article Info
1 Unità Operativa di Chirurgia Generale, Azienda Ospedaliera “San Giuseppe Moscati”, Avellino
2 Unità Operativa di Anatomia Patologica, Azienda Ospedaliera “San Giuseppe Moscati”, Avellino
3 Unità Operativa di Diagnostica per Immagini, Azienda Ospedaliera “San Giuseppe Moscati”, Avellino
4 Unità Operativa di Medicina Nucleare, Azienda Ospedaliera “San Giuseppe Moscati”, Avellino
Abstract
Sentinel node is defined as the first lymphnode receiving limphatic drain from the breast. Several studies show a very low recurrence rate to axillary and locoregional nodes in sentinel node negative patients who did not undergo axillary dissection. Our study aims to verify if complete axillary dissection could be replaced by sentinel node biopsy (SNB) in the staging and treatment of breast cancer. From January 2005 to December 2008, 377 patients (mean age 57.63) underwent SNB in the General Surgery unit of “San Giuseppe Moscati” Hospital in Avellino (Italy). All the patients underwent SNB with local anesthesia. Histologic studies were performed using GIVOM protocol (Veneto Breast cancer interdisciplinary group). Sixty five patients (17.2%) underwent a radical mastectomy with SNB and 312 (82.6%) patients underwent a quadrantectomy with SNB. Of this last group, 178 (47.2%) underwent a superior quadrant excision with SNB, 77 (20.4%) an inferior quadrant excision with SNB and 57 (15.1%) a central quadrant excision with SNB. Ductal carcinoma represented 57.3% of the tumous detected, lobular carcinoma was diagnosed in 16.4% of the cases, intraductal microinvasive carcinoma in 10.3%, ductal carcinoma in situ in 5.8% while the other histotypes were diagnosed in 10% of the tumours. All SNB+ patients (34.5%) underwent a radical axillary dissection in general anesthesia Sixty nine (53%) patients were diagnosed with axillary node metastasis, after axillary dissection Micrometastasis resulted in 19.6 % of the excised patients. The prevalence of axillary node metastasis was 26.4% (581/2198), while the incidence was 34.5% (130/377). The first axillary lymphnodes level was metastasized in 65.8% patients who had undergone an axillary dissection, level I and II in 26.8% and all the levels in 7.4%. Only one case (0.4%) of nodal metastatic recurrence has been diagnosed in patients who had undergone SNB alone, after a mean follow-up of 28.5 month Apart from showing a very high diagnostic and staging accuracy, the high level of SN detection associated with a high predictive rate underline a lower complicantions rate if compared to complete nodal dissection.
Keywords
- Axillary dissection
- Axillary lymphnodes recurrence
- Sentinel node dissection
